Medpace Holdings (MEDP) Revenue (2015 - 2026)

Medpace Holdings has reported Revenue for 12 years, with the latest figure at $706.6 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 26.5% year-over-year to $706.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 billion (up 24.19% YoY), and the FY2025 full-year result was $2.5 billion, up 19.97% from the prior year.
• Revenue for Q1 2026 stood at $706.6 million, roughly flat from $708.4 million in the prior quarter.
• The five-year high for Revenue was $708.4 million in Q4 2025, with the low at $330.9 million in Q1 2022.
• Historically, Revenue has averaged $511.3 million across 5 years, with a median of $511.0 million in 2024.
• Annual changes were most pronounced in 2024 — Revenue gained 7.66% — and 2025, when it surged 32.03%.
• Medpace Holdings' Revenue stood at $394.1 million in 2022, then increased by 26.47% to $498.4 million in 2023, then grew by 7.66% to $536.6 million in 2024, then surged by 32.03% to $708.4 million in 2025, then slipped by 0.26% to $706.6 million in 2026.
• The last three Revenue figures came in at $706.6 million (Q1 2026), $708.4 million (Q4 2025), and $659.9 million (Q3 2025), per Business Quant data.